Not exact matches
CB - 1158 has single agent anti-
tumor activity in syngeneic mouse
tumor models that has been demonstrated to act through an immune mechanism.
Many studies have shown serum TK1 to be a valuable cancer biomarker, but most previous assays have been enzyme -
activity based and may underestimate its presence
in solid
tumors.
In this special section of Science, expert contributors retrace the long and tortuous path leading to the mapping and identification of the BRCA1 gene; discuss the ways in which BRCA mutation status has been integrated into the clinical management of patients in high - risk families; and highlight the role of the BRCA proteins in preserving the structural and numerical integrity of chromosomes throughout the cell cycle, a function that may explain their tumor suppressor activit
In this special section of Science, expert contributors retrace the long and tortuous path leading to the mapping and identification of the BRCA1 gene; discuss the ways
in which BRCA mutation status has been integrated into the clinical management of patients in high - risk families; and highlight the role of the BRCA proteins in preserving the structural and numerical integrity of chromosomes throughout the cell cycle, a function that may explain their tumor suppressor activit
in which BRCA mutation status has been integrated into the clinical management of patients
in high - risk families; and highlight the role of the BRCA proteins in preserving the structural and numerical integrity of chromosomes throughout the cell cycle, a function that may explain their tumor suppressor activit
in high - risk families; and highlight the role of the BRCA proteins
in preserving the structural and numerical integrity of chromosomes throughout the cell cycle, a function that may explain their tumor suppressor activit
in preserving the structural and numerical integrity of chromosomes throughout the cell cycle, a function that may explain their
tumor suppressor
activity.
The
tumor - derived peptide is identical
in biological
activity and similar
in physiochemical properties to the still uncharacterized growth hormone - releasing factor present
in extracts of hypothalamic tissues.
«These results also provide a rationale to explore the clinical
activity of an OX40 agonist antibody
in combination with GSK2636771
in cancer patients with PTEN loss
tumors.»
Greene and first author and doctoral student Gregory P. Way used machine learning to classify abnormal protein
activity in tumors.
«Physicians managing cervical cancer patients should test for HPV oncogene expression
in these
tumors and consider personalized treatment depending on HPV
activity,» Banister said.
SapC - DOPS (saposin - C dioleoylphosphatidylserine), is a nanovesicle drug that has shown
activity in glioblastoma, pancreatic cancer and other solid
tumors in preclinical studies.
So scientists choose the lymphocytes with the greatest
tumor - fighting
activity, grow a large population of them
in the lab, then infuse them back into the patient.
When researchers screened a library of more than 200 drugs and related compounds for
activity against embryonal subtype
tumor cells from three patients, the most promising results involved drugs that increased oxidative stress
in tumor cells.
In pancreatic cancer, their
activity boosts
tumor growth and spread, and may also help suppress T cells and other immune elements that would otherwise attack the
tumor.
Indeed, the authors point out that Ipilimumab might better effect recurrence - free survival than adjuvant interferon and should be considered as an option by oncologists
in this field considering its
activity across subgroups including those with high
tumor burden.
They report that the test can detect significant drops
in the metabolic
activity levels of all three types of
tumors within 72 hours when exposed to an effective drug whereas
tumors that were resistant to a drug show no change.
The border between
tumor proliferating region and the necrotic region can be clearly visualized down to single cell with sharp contrast
in glucose uptake
activity.
To overcome these problems, Min and his team developed a new modality to visualize glucose uptake
activity inside single cells based on stimulated Raman scattering (SRS) imaging, and demonstrated its use
in live cancer cells,
tumor xenograft tissues, primary neurons and mouse brain tissues.
This technique is able to distinguish cancer cell lines with differing metabolic
activities and reveals heterogeneous uptake patterns
in neurons, mouse brain tissues and
tumor tissues with clear cell - to - cell variations.
In collaboration with the University of Texas Southwestern Medical Center (UTSW) in Dallas, the researchers found that the tumor - suppressive activity of geranylgeraniol was accompanied by down - regulation of HMG CoA reductase, a key enzyme in the mevalonate pathway that provides essential intermediates for the posttranslational modification of growth - related proteins such as Ras, nuclear lamins and insulin - like growth factor receptor
In collaboration with the University of Texas Southwestern Medical Center (UTSW)
in Dallas, the researchers found that the tumor - suppressive activity of geranylgeraniol was accompanied by down - regulation of HMG CoA reductase, a key enzyme in the mevalonate pathway that provides essential intermediates for the posttranslational modification of growth - related proteins such as Ras, nuclear lamins and insulin - like growth factor receptor
in Dallas, the researchers found that the
tumor - suppressive
activity of geranylgeraniol was accompanied by down - regulation of HMG CoA reductase, a key enzyme
in the mevalonate pathway that provides essential intermediates for the posttranslational modification of growth - related proteins such as Ras, nuclear lamins and insulin - like growth factor receptor
in the mevalonate pathway that provides essential intermediates for the posttranslational modification of growth - related proteins such as Ras, nuclear lamins and insulin - like growth factor receptors.
The researchers further found that miR - 486 is itself regulated by the
tumor - suppressor gene p53, the most frequently altered gene
in human cancers, and that
activity of miR - 486 is partially dependent upon functional p53.
«Interestingly, we found that
activity of pembrolizumab was seen
in both PD - L1 - positive and - negative
tumors.
«The finding that certain cell signaling lipids change the
activity of an oncogenic Ras protein, suggests that we might be able to interfere with
tumor progression by inhibiting the enzymes which make the specific cell signaling lipid
in cells,» Buck said.
Moffitt Cancer Center, a leader
in molecular cancer research, and a research team led by Jia Fang, Ph.D., assistant member of the
Tumor Biology Department, has discovered a new way to control the
activity of SETDB1, a protein that is often upregulated
in cancer.
In the current study, decreasing Treg
activity permitted the immune system to attack an unwelcome visitor — a
tumor.
For most available T cell immunotherapies, T cells (which play a central role
in defending the body against illness) are engineered to recognize and eliminate
tumors, but their
activity is not specifically controlled, leading to toxicity and unwanted side effects
in patients as a result of inflammation or
in some cases suboptimal response to treatment.
By contrast, a signal of
tumor activity increased sixty-fold
in mice treated with the widely used chemotherapy drug gemcitabine.
As these compounds are already approved for clinical trails
in pediatric brain
tumors, these findings suggest that drugs inhibiting MEK
activity could offer a new therapy option for children with these devastating
tumors.
In humans, a similar protein complex called CSN and its subunit CSN6 is now believed to be a cancer - causing gene that impacts
activity of another gene (Myc) tied to
tumor growth.
More
activity of the neuroligin - 3 gene
in high - grade gliomas was linked to shorter survival among patients with these
tumors.
Monje's team identified a specific protein, called neuroligin - 3, which is largely responsible for the increase
in tumor growth associated with neuronal
activity in the cerebral cortex.
Investigating how organs far from
tumors contribute to cancer progression should lead us to ways of manipulating those systemic
activities in therapy.
«Brain
tumor growth stimulated by nerve
activity in the cortex, study finds.»
Crews noted that RNA splicing - targeted agents have been shown to have
activity in a variety of solid
tumors so the findings may be relevant to a variety of cancers, such as breast and drug - resistant melanoma.
Both the number and
activity of osteoblasts — cells that produce and reshape bone tissue — were increased within the bone marrow of mice with lung
tumors compared with cancer - free animals; and reducing the number of osteoblasts
in mice not only limited neutrophil infiltration of
tumors but also interrupted
tumor progression.
Deadly brain
tumors called high - grade gliomas grow with the help of nerve
activity in the cerebral cortex, according to a new study by researchers at the Stanford University School of Medicine.
Lutz and Falkowski cite one study where unique chemical compounds isolated from an actinomycete strain inhabiting deep - sea sediments about 3.3 kilometers down
in the South China Sea have shown potent
activities against three cancerous
tumor cell lines and also showed antibacterial
activities.
Images taken with a fluorescent microscope show the
activity of a kinase (green)
in tumor cells (bottom) compared to normal cells (top).
A new study shows coibamide A has potent anti-cancer
activity in mice and cell cultures that model brain
tumors and triple negative breast cancer, two of the most aggressive and difficult - to - treat types of cancer.
These new findings suggest that a drug that brings well - being gene
activities further down could significantly boost the killer
activity of Myc
in tumor cells.»
«We found polyploidy
in liver cells did not strongly affect the
activity of some oncogenes, but it did protect against the loss of
tumor suppressor genes.
«When we compared the gene signature
activity of glioblastoma cells from around 60 patients we found that a large number of patients could be divided into subgroups that showed a correlation between gene
activity,
tumor cell characteristics and cell of origin similar to the one we had seen
in the mouse study.
McDonnell said is lab is continuing the research, including finding ways to induce cells to eject cholesterol, reverse the inhibition of CYP27A1
activity, or introduce compounds that interfere with cholesterol - production
in the
tumor.
The therapy not only killed cells at the primary
tumor site, but also
in distant metastases by «bystander» antitumor
activity driven by the secreted MDA - 7 / IL - 24 protein.
This approach resulted
in the persistent clonal repopulation of T cells
in those cancer patients, with the transferred cells proliferating
in vivo, displaying functional
activity, and trafficking to
tumor sites.
When there is a mutation
in one or both of the PTEN genes, it interferes with the protein's enzymatic
activity and, as a result inhibits its
tumor suppressing ability.
The researchers had previously built a mathematical model that simulates the
activity of a blood - vessel - growth - promoting protein called VEGF
in a mouse
tumor.
The activation of this signaling pathway progressively increased
in different types of gliomas, with the highest
activity seen
in patients with glioblastoma, a particularly difficult - to - treat form of brain cancer that represents approximately 15 percent of all brain
tumors.
In a series of studies led by Dr. Arun Sharma, associate professor of pharmacology and Dr. Shantu Amin, professor of pharmacology, both of Penn State College of Medicine, researchers designed and synthesized a compound called napthalamide - isoselenocyanate — NISC - 6 — to inhibit both the Akt1 pathway and human topoisomerase IIα — topo IIα —
activity, which contribute to melanoma
tumor growth.
Of note, several proteins involved
in the
tumor necrosis factor, or TNF, pathway increased
in activity during the induction and execution phases.
Some studies
in mice have shown that elevated telomerase
activity leaves the animals more susceptible to skin
tumors and breast cancer, so maybe there is no free lunch.
Next, they genetically modify a fruit fly to dial up or down the
activity of those genes, and, if possible, do so
in the location where the original human
tumor was found.
While this trial - s primary efficacy goals are to evaluate anti-tumor
activity in PD - L1 positive
tumors, preliminary exploration of antitumor
activity will also be conducted
in a subset of PD - L1 negative
tumors based upon response observed
in PD - L1 positive
tumors or lymphoma
in this trial.